πŸ•΅οΈ Harmony Biosciences Holdings, Inc. ($HRMY)

SEC insider & ownership activity, last 12 months Β· CIK 1802665 Β· every row links its SEC filing

Over the last 12 months insiders sold $4.3M with no open-market buying against it. Sandip Kapadia sold $1.8M through a program of 12 sale notices averaging $745K (Nov–Jan). 3 planned sales are pending, the largest $26.6M (Valor IV Pharma Holdings LLC). No red-flag 8-Ks in the window.

Oct 2025: net +$0 Nov 2025: net -$120K Dec 2025: net -$1.8M Jan 2026: net -$892K Feb 2026: net +$0 Mar 2026: net +$0 Apr 2026: net +$0 May 2026: net +$0 Jun 2026: net +$0 Jul 2026: net +$0 Aug 2026: net +$0 Sep 2026: net -$1.5M
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

0 buyers, $0 (0 lots) Β· 3 sellers, $4.3M (10 lots)

InsiderBuysBoughtSellsSoldLast
Sandip Kapadia0– 4$1.8MJan 26, 2026
Budur Kumar0– 4$1.5MSep 8, 2026
Jeffrey M. Dayno0– 2$1.0MDec 12, 2025

5%+ holders

HolderStakeClassScheduleEvent
BlackRock, Inc. 11.3% 13GJul 28, 2026 filing β†—
Marshman Fund Trust II 10.6% 13GFeb 10, 2025 filing β†—
FMR LLC 5.4% 13GFeb 5, 2026 filing β†—
Abigail P. Johnson 5.4% 13GFeb 5, 2026 filing β†—
Vanguard Portfolio Management 5.1% 13GJul 31, 2026 filing β†—

Planned insider sales (Form 144)

SellerPlannedApprox. sale date
Kumar Budur$76KSep 16, 2026 filing β†—
Kumar Budur$1.2MSep 8, 2026 filing β†—
Kumar Budur$230KSep 4, 2026 filing β†—
Valor IV Pharma Holdings LLC$26.6MAug 7, 2026 filing β†—
Sandip Kapadia$924KJul 2, 2026 filing β†—
Sandip Kapadia$1.8MJun 30, 2026 filing β†—
Sandip Kapadia$1.6MJun 26, 2026 filing β†—
Sandip Kapadia$154KJun 24, 2026 filing β†—
Sandip Kapadia$943KJun 9, 2026 filing β†—
Sandip Kapadia$70KJun 5, 2026 filing β†—
Sandip Kapadia$233KJun 4, 2026 filing β†—
Sandip Kapadia$1.4MMay 8, 2026 filing β†—
Sandip Kapadia$138KJan 26, 2026 filing β†—
Sandip Kapadia$755KJan 15, 2026 filing β†—
Jeffrey M. Dayno$1.0MDec 12, 2025 filing β†—
Sandip Kapadia$765KDec 5, 2025 filing β†—
Sandip Kapadia$114KNov 21, 2025 filing β†—

Material events (8-K)

ItemEvent date
Earnings (2.02)Aug 4, 2026 filing β†—
Reg FD disclosure (7.01)Aug 4, 2026 filing β†—
Financial Statements and Exhibits (9.01)Aug 4, 2026 filing β†—
Earnings (2.02)Jul 16, 2026 filing β†—
Officer/director changes (5.02)Jul 16, 2026 filing β†—
Reg FD disclosure (7.01)Jul 16, 2026 filing β†—
Financial Statements and Exhibits (9.01)Jul 16, 2026 filing β†—
Shareholder vote (5.07)May 14, 2026 filing β†—
Earnings (2.02)May 7, 2026 filing β†—
Reg FD disclosure (7.01)May 7, 2026 filing β†—
Financial Statements and Exhibits (9.01)May 7, 2026 filing β†—
Officer/director changes (5.02)Apr 14, 2026 filing β†—
Reg FD disclosure (7.01)Apr 14, 2026 filing β†—
Financial Statements and Exhibits (9.01)Apr 14, 2026 filing β†—
Officer/director changes (5.02)Mar 31, 2026 filing β†—
Reg FD disclosure (7.01)Mar 31, 2026 filing β†—
Financial Statements and Exhibits (9.01)Mar 31, 2026 filing β†—
Earnings (2.02)Feb 24, 2026 filing β†—
Reg FD disclosure (7.01)Feb 24, 2026 filing β†—
Financial Statements and Exhibits (9.01)Feb 24, 2026 filing β†—
Earnings (2.02)Jan 12, 2026 filing β†—
Reg FD disclosure (7.01)Jan 12, 2026 filing β†—
Financial Statements and Exhibits (9.01)Jan 12, 2026 filing β†—
Earnings (2.02)Nov 4, 2025 filing β†—
Reg FD disclosure (7.01)Nov 4, 2025 filing β†—
Financial Statements and Exhibits (9.01)Nov 4, 2025 filing β†—
Earnings (2.02)Oct 23, 2025 filing β†—
Financial Statements and Exhibits (9.01)Oct 23, 2025 filing β†—
Reg FD disclosure (7.01)Sep 24, 2025 filing β†—
Financial Statements and Exhibits (9.01)Sep 24, 2025 filing β†—